Last reviewed · How we verify

NCT07083726

Smart Steps to Growth: Unleashing AI for Assessing Motor Skills in School Children

Active, enrolled Last updated 5 September 2025
What this trial tests

trial in AIMAS in 250 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 August 2025
Primary endpoint
31 July 2028
31 July 2028

Quick facts

Lead sponsorChang Gung Memorial Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment250
Start date1 August 2025
Primary completion31 July 2028
Estimated completion31 July 2028
Sites1 location across Taiwan

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 6 to 12, any sex, with AIMAS or Developmental Coordination Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop an AI-based automated motor function assessment system (AIMAS) to improve early identification of developmental coordination disorder (DCD) in school-age children. The main hypothesis for this study is: Integrating AI into motor skill assessments will enhance the reliability, validity, efficiency, and accuracy of evaluating motor performance in children aged 6 to 12.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07083726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing